Andreas Boeckl Dispersa's guest appearances

Andreas Boeckl Dispersa

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Andreas Boeckl, founder, Dispersa Labs is bringing to the market Sula, breathable cannabis, which is inhaled from measured doses using a device that does not require combustion.  This approach to dosing medical cannabis for specific conditions like neurological disorders, stress, anxiety, PTSD, and pain provides much faster relief than edible cannabis and allows for more flexibility for where the cannabis can be administered.  Andreas also emphasizes the value of this solution for researchers who are studying the use of cannabinoids. @breathesula  #cannabis  #BreatheSula  #PTSD #cannabinoids Breathesula.com Download the transcript here

Andreas Boeckl, founder, Dispersa Labs is bringing to the market Sula, breathable cannabis, which is inhaled from measured doses using a device that does not require combustion.  This approach to dosing medical cannabis for specific conditions like neurological disorders, stress, anxiety, PTSD, and pain provides much faster relief than edible cannabis and allows for more flexibility for where the cannabis can be administered.  Andreas also emphasizes the value of this solution for researchers who are studying the use of cannabinoids. @breathesula  #cannabis  #BreatheSula  #PTSD #cannabinoids <a href="http://breathesula.com" rel="noopener nofollow" target="_blank">Breathesula.com</a> <a href="http://empoweredpatientradio.com/breathable-cannabis-addresses-dosing-challenges-with-andreas-boeckl-dispersa-labs-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Breathable Cannabis Addresses Dosing Challenges with Andreas Boeckl Dispersa Labs